SuperworthbioAffinity Technologies shares outstanding BIAF
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 348.5K
- On a year earlier
- +552.8%
- more shares
bioAffinity Technologies had 348.5K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 552.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 296K | +801% |
| FY2024 | 32.8K | +58% |
| FY2023 | 20.7K | +11% |
| FY2022 | 18.6K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 348.5K | +553% | |
| Q1 FY26 | 299.7K | +730% | |
| Q4 FY25 | 296K | +801% | |
| Q3 FY25 | 71.1K | +158% | |
| Q2 FY25 | 53.4K | +111% | |
| Q1 FY25 | 36.1K | +64% | |
| Q4 FY24 | 32.8K | +58% | |
| Q3 FY24 | 27.5K | +42% | |
| Q2 FY24 | 25.3K | +34% | |
| Q1 FY24 | 22K | +18% | |
| Q4 FY23 | 20.7K | +11% | |
| Q3 FY23 | 19.3K | +107% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on bioAffinity Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.